FDA approved new immunotherapy regimen for patients with melanoma
Published Date: 3/23/2022
Source: sciencedaily.com
The U.S. Food and Drug Administration has approved a novel therapy for patients with metastatic or inoperable melanoma, an aggressive type of skin cancer.
